Clinical use of sensitive assays for thyroid-stimulating hormone

Journal of General Internal Medicine

Volumn 11, Issue 2, 1996, Pages 115-127

  Masters, Philip A ^a   Simons, Richard J ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

hyperthyroidism; hypothyroidism; thyroid function tests; thyrotropin

Indexed keywords

THYROTROPIN;

ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HORMONE DETERMINATION; HYPERTHYROIDISM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; HYPOTHYROIDISM; THYROID FUNCTION TEST;

EID: 0030009414     PISSN: 08848734     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02599589     Document Type: Article

References (102)

1. Greenspan SL, Klibanski A, Schoenfeld D, Ridgway EC. Pulsatile secretion of thyrotropin in man. J Clin Endocrinol Metab, 1986;63:661-8.
2. Vanhaelst L, Van Cauter E, Degaule JP, Golstein J. Circadian variations of serum thyrotropin levels in man. J Clin Endocrinol Metab. 1972;35:479-82.
3. Nickoloff JT, Spencer CA. The use and misuse of the sensitive thyrotropin assays. J Clin Endocrinol Metab. 1990;71:553-8.
4. Ridgway EC. Thyrotropin radioimmunoassays: birth. life, and demise. Mayo Clin Proc. 1988;63:1028-34.
5. Spencer CA, Schwarzbein D, Guttler RB, LoPresti JS, Nickoloff JT. Thyrotropin (TSH)-releasing hormone stimulation test responses employing third and fourth generation TSH assays. J Clin Endocrinol Metab. 1993;76:494-8.
6. Larsen PR, Alexander NM, Chopra IJ, et al. Revised nomenclature for tests of thyroid hormones and thyroid-related proteins in serum. Clin Chem. 1987;33:2114-7.
7. Hay ID, Bayer MF, Kaplan MM, et al. American Thyroid Association assessment of current thyroid hormone and thyrotropin measurements and guidelines for future clinical assays. Clin Chem. 1991;37:2002-8.
8. 4 estimate or sensitive TSH measurement? J Clin Immunoassay. 1989;12:82-9.
9. Spencer CA, Takeuchi M, Kazarosyan M, MacKenzie F, Beckett GJ, Wilkinson E. Interlaboratory/intermethod differences in functional sensitivity of immunometric assays of thyrotropin (TSH) and impact on reliability of measurement of subnormal concentrations of TSH. Clin Chem. 1995;41:367-74.
10. Simoni M, Velardo A, Montanini V, et al. Circannual rhythm of plasma thyrotropin in middle-aged and old euthyroid subjects. Horm Res. 1990;33:184-9.
11. Olsson T, Viitanen M, Hagg E, et al. Hormone in 'young' and 'old' elderly: pituitary-thyroid and pituitary-adrenal axes. Gerontology. 1989;35:144-52.
12. Hershman JM, Pekary AE, Berg L, Solomon DH, Sawin CT. Serum thyrotropin and thyroid hormone levels in elderly and middle-aged euthyroid persons. J Am Geriatr Soc. 1993;41:823-8.
13. van Coevorden A, Laurent E, Decoster C, et al. Decreased basal and stimulated thyrotropin secretion in healthy elderly men. J Clin Endocrinol Metab. 1989;69:177-85.
14. Runnels BL, Garry PJ, Hunt WC, Standefer JC. Thyroid function in a healthy elderly population: implications for clinical evaluation. J Gerontol. 1991;46:B39-44.
15. Szabolcs I, Ploenes C, Beyer M, Bernard W, Herrman J. Reference intervals for serum thyrotropin: dependence on the population investigated. Exp Clin Endocrinol. 1991;98:23-31.
16. Schectman JM, Kallenberg GA, Schumacher RJ, Hirsch RP. Yield of hypothyroidism in symptomatic primary care patients. Arch Intern Med. 1989;149:861-4.
17. Schectman JM, Kallenberg GA, Hirsch RP, Schumacher RJ. Report of an association between race and thyroid stimulating hormone level. Am J Public Health. 1991;81:505-6.
18. Bagchi N, Brown TR, Parish RF. Thyroid dysfunction in adults over age 55 years. Arch Intern Med. 1990;150:785-7.
19. Chan BY, Swaminathan R. Serum thyrotropin concentration measured by sensitive assays in normal pregnancy. Br J Obstet Gynaecol. 1988;95:1332-6.
20. Glinoer D, DeNayer P, Bourdoux P, et al. Regulation of maternal thyroid during pregnancy. J Clin Endocrinol Metab. 1990;71:276-85.
21. Ballabio M, Poshyachinda M, Ekins RP. Pregnancy-induced changes in thyroid function: role of human chorionic gonadotropin as putative regulator of maternal thyroid. J Clin Endocrinol Metab. 1991;73:824-31.
22. Burrow GN. Thyroid function and hyperfunction during gestation. Endocr Rev. 1993;14:194-202.
23. Busnardo I, Bui F, Girelli ME. Different rates of thyrotropin suppression after total body scan in patients with thyroid cancer: effect of regular doses of thyroxine and triiodothyronine. J Endocrinol Invest. 1983;6:35-40.
24. Spencer CA, LoPresti JS, Patel S, et al. Applications of a new chemiluminescent thyrotropin assay to subnormal measurement. J Clin Endocrinol Metab. 1990;70:453-60.
25. Mandel SJ, Brent GA, Larsen PR. Levothyroxine therapy in patients with thyroid disease. Ann Intern Med. 1993;119:491-502.
26. Helfand M, Crapo LM. Monitoring therapy in patients taking levothyroxine. Ann Intern Med. 1990;113:450-4.
27. Kaptein EM, Spencer CA, Kamiel MB, Nickoloff JT. Prolonged dopamine administration and thyroid hormone economy in normal and critically ill subjects. J Clin Endocrinol Metab. 1980;51:387-93.
28. Re RN, Kourides IA, Ridgway EC, Weintraub BD, Maloof F. The effect of glucocorticoid administration on human pituitary secretion of thyrotropin and prolactin. J Clin Endocrinol Metab. 1976;43:338-46.
29. 4, dexamethasone (DEX) and dopamine (DA) suppression of TSH in man. Clin Res. 1990;38:100A.
30. Davies PH, Franklyn JA. The effects of drugs on tests of thyroid function. Eur J Clin Pharmacol. 1991;40:439-51.
31. Fradkin JE, Wolff J. Iodine-induced thyrotoxicosis. Medicine. 1983;62:1-14.
32. Braverman LE, Woeber KA, Ingbar SH. Induction of myxedema by iodine in patients euthyroid after radioiodine or surgical treatment of diffuse toxic goitre. N Engl J Med. 1969;281:816-21.
33. Braverman LE, Ingbar SH, Vagenakis AG, Adams L, Maloof F. Enhanced susceptibility to iodide myxedema in particular with Hashimoto's disease. J Clin Endocrinol Metab. 1971;32:515-21.
34. Trip MD, Wiersinga W, Plomp TA. Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism. Am J Med. 1991;91:507-11.
35. Figge HL, Figge J. The effects of amiodarone on thyroid hormone function: a review of the physiology and clinical manifestations. J Clin Pharmacol. 1990;30:580-95.
36. Nademanee K, Singh BN, Callahan B, Hendrickson JA. Hershman JM, Amiodarone, thyroid hormone indexes, and altered thyroid function: long term serial effects in patients with cardiac arrhythmias. Am J Cardiol. 1986;58:981-6.
37. Singh BN, Nademanee K, Amiodarone and thyroid function: clinical implications during antiarrhythmic therapy. Am Heart J, 1983;106:857-69.
38. Melmed S, Nademanee K, Reed AW, Hendrickson JA, Singh BN, Hershman JM. Hyperthyroxinemia with bradycardia and normal thyrotropin secretion after chronic amiodarone administration. J Clin Endocrinol Metab. 1981;53:997-1001.
39. Wiersinga WM, Endert E, Trip MD, Verhaest-deJong N. Immunoradiometric assay of thyrotropin in plasma: its value in predicting response to thyroliberin stimulation and assessing thyroid function in amiodarone-treated patients. Clin Chem. 1986;32:433-6.
40. Burman P, Totterman TH, Karlsson FA. Thyroid autoimmunity in patients on long term therapy with leukocyte-derived interferon. J Clin Endocrinol Metab. 1986;63:1086-90.
41. Schultz M, Muller R, von zur Muhlen A, Brabent G. Induction of hypothyroidism by interferon alpha-2-b. Lancet. 1989;1:1452.
42. Ronnblom LE, Alm GV, Oberg KE. Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Ann Intern Med. 1991;115:178-83.
43. Lisker-Melman M, DiBisceglie AM, Usala SJ, Weintraub B, Murray LM, Hoofnagle JH. Development of thyroid disease during therapy of chronic viral hepatitis with interferon alpha. Gastroenterology. 1993;102:2155-60.
44. Kamikubo K, Takami R, Suwa T, et al. Case report: silent thyroiditis developed during alpha-interferon therapy. Am J Med Sci. 1993;306:174-6.
45. Watanabe U, Hashimoto E, Hisamitsu T, Obata H, Hayashi N, The risk factor for development of thyroid disease during interferon-alpha therapy for chronic hepatitis C. Am J Gastroenterol. 1994; 89:399-403.
46. DuBuis JM, Burger AG. Thyroid-stimulating hormone measurements by immunoradiometric assay in severely ill patients. Lancet. 1986;2:1036-7.
47. Bayer MF, Macoviak JA, McDougal IR. Diagnostic performance of sensitive measurements of serum thyrotropin during severe nonthyroidal illness: the role in the diagnosis of hyperthyroidism. Clin Chem. 1987;33:2178-84.
48. Spencer CA, Eigen A, Shen D, et al. Specificity of sensitive assays of thyrotropin (TSH) used to screen for thyroid disease in hospitalized patients. Clin Chem. 1987;33:1391-6.
49. Chopra I, Solomon DH, Huang T-S, Serum thyrotropin in hospitalized psychiatric patients: evidence for hyperthyrotropinemia as measured by an ultrasensitive thyrotropin assay. Metabolism. 1990;5:538-43.
50. Hein MD, Jackson IMD. Review: thyroid function in psychiatric illness. Gen Hosp Psychiatry. 1990;12:232-44.
51. Hobs AS, Dempsey MA, Ladenson PW, Polk BF. Endocrine disorders in men infected with human immunodeficiency virus. Am J Med. 1987;84:611-6.
52. Merenich JA, McDermott MT, Asp AA, Harrison SM, Kidd GS. Evidence of endocrine involvement early in the course of human immunodeficiency virus infection. J Clin Endocrinol Metab. 1990;70: 566-71.
53. Tang WW, Kaptein EM. Thyroid hormone levels in the acquired immunodeficiency syndrome (AIDS) or AIDS related complex. West J Med. 1989;151:627-31.
54. LoPresti JS, Fried JC, Spencer CA, Nickoloff JT. Unique alterations of thyroid hormone indices in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med. 1989;110:970-5.
55. Olivieri A, Sorcini M, Battisti P, et al. Thyroid hypofunction related with the progression of human immunodeficency virus infection. J Endocrinol Invest. 1993;16:407-13.
56. Aizawa T, Koizumi Y, Yamada T, et al. Difference in pituitary-thyroid feedback regulation in hypothyroid patients, depending on the severity of hypothyroidism. J. Clin Endocrinol Metab. 1978;47:560-5.
57. 3. and TSH levels in primary hypothyroidism during replacement therapy with thyroxine. Metabolism. 1983;32:745-7.
58. Fish LH, Schwartz HL, Cavanaugh J, Steffes MW, Bantle JP, Oppenheimer JH. Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism. N Engl J Med. 1987;316:764-70.
59. Maeda M, Kuzuya N, Masuyama Y, et al. Changes in serum triiodothyronine, thyroxine, and thyrotropin during treatment with thyroxine in severe primary hypothyroidism. J Clin Endocrinol Metab. 1976;43:10-7.
60. England ML, Hershman JM. Serum TSH as an aid to monitoring compliance with thyroid hormone therapy in hypothyroidism. Am J Med Sci. 1986;292:264-6.
61. Kabadi UM. "Subclinical hypothyroidism"-natural course of the syndrome during a prolonged follow-up study. Arch Intern Med. 1993;153:957-61.
62. Parle JV, Franklyn JA, Cross KW, Jones SC, Parle JV. Prevalence and follow-up of abnormal thyrotropin (TSH) concentrations in the elderly In the United Kingdom. Clin Endocrinol. 1991;34:77-83.
63. Tunbridge WM, Brewis M, French JM, et al. Natural history of autoimmune thyroiditis. Br Med J. 1981;282:258-62.
64. Rosenthal MJ, Hunt WC, Garry PJ, Goodwin JS. Thyroid failure in the elderly: microsomal antibodies as discriminant for therapy. JAMA. 1987;258:209-13.
65. Lazarus JH, Burr ML, McGregor AM, et al. The prevalence and progression of autoimmune thyroid disease in the elderly. Acta Endocrinol. 1984;106:199-202.
66. Brochmann H, Bjoro T, Gaarder PI, Hanson F, Frey HM. Prevalence of thyroid dysfunction in elderly subjects. A randomized study in a Norwegian rural community. Acta Endocrinol. 1988;117:7-12.
67. Davies PH, Franklyn JA, Daykin J, Sheppard MC. The significance of TSH values measured in a sensitive assay in the follow-up of hyperthyroid patients treated with iodine. J Clin Endocrinol Metab. 1992;74:1189-94.
68. Toft AD, Irvine WU, Seth J, Cameron EHD. How often should patients be reviewed after treatment with iodine 131 for thyrotoxicosis? BMJ. 1978;2:1115-7.
69. 131 for thyrotoxicosis. BMJ. 1974;3:152-3.
70. Hamblin PS, Dyer SA, Mohr VS, et al. Relationship between thyrotropin and thyroxine changes during recovery from severe hypothyroxinemia of critical illness. J Clin Endocrinol Metab. 1986;62:717-22.
71. Spencer CA. Clinical utility and cost-effectiveness of sensitive thyrotropin assays in ambulatory and hospitalized patients. Mayo Clin Proc. 1988;63:1214-22.
72. Kaptein EM, Weiner JM, Robinson WJ, Wheeler WS, Nickoloff JT. Relationship of altered thyroid hormone indices to survival in nonthyroidal illness. Clin Endocrinol. 1982;16:565-74.
73. Faber J, Kirkegaard C, Rasmussen B, Westh H, Busch-Sorensen M, Jensen IW. Pituitary thyroid axis in critical illness. J Clin Endocrinol Metab. 1987;65:315-20.
74. Topliss DJ, White EL, Stockigt JR. Significance of thyrotropin excess in untreated primary adrenal insufficiency. J Clin Endocrinol Metab. 1980;50:52-6.
75. Wynne AG, Gharib H, Scheithauer BW, Davis DH, Freeman SL, Horvath E. Hyperthyroidism due to inappropriate secretion of thyrotropin in 10 patients. Am J Med. 1992;92:15-24.
76. Faglia G, Beck-Peccoz P, Piscitelli G, Medri G. Inappropriate secretion of thyrotropin by the pituitary Horm Res. 1987;26:79-99.
77. Refetoff S, Weiss RE, Usala SJ. The syndromes of resistance to thyroid hormone. Endocr Rev. 1993;14:348-99.
78. Faglia G, Bitensky L, Pinchera A, et al. Thyrotropin secretion in patients with central hypothyroidism: evidence for reduced biological activity of immunoreactive thyrotropin. J Clin Endocrinol Metab. 1979;48:989-98.
79. Suntburnthepvarakul T, Gottschalk ME, Hayashi Y, Refetoff S. Brief report: resistance to thyrotropin caused by mutations in the thyrotropin receptor gene. N Engl J Med. 1995;332:155-60.
80. Franklyn JA, Black EG, Betteridge J, Sheppard MC. Comparison of second and third generation methods for measurement of serum thyrotropin in patients with overt hyperthyroidism, patients receiving thyroxine therapy, and those with non-thyroidal illness. J Clin Endocrinol Metab. 1994;78:1368-71.
81. Ross DS, Ardisson LJ, Meskell MJ. Measurement of thyrotropin In clinical and subclinical hyperthyroidism using a new chemiluminescent assay. J Clin Endocrinol Metab. 1989;68:684-8.
82. 3) toxicosis. Am J Med. 1994;96:229-34.
83. Bitton RE, Wexler C. Free triidothyronine thyrotoxicosis: a distinct entity. Am J Med. 1990;88:531-3.
84. Simons RJ, Manni A, Fang S-H, Braverman L. Free triidothyronine toxicosis in a patient with multinodular goiter. Am J Med. 1990;88:689-92.
85. Eggertsen R, Petersen K, Lundberg P-A, Nystrom E, Lindstedt G. Screening for thyroid disease in a primary care unit with a thyroid stimulating hormone assay with a low detection limit. BMJ. 1988; 297:1586-92.
86. Sawin CT, Geller A, Kaplan M, Bacharach P, Wilson PWF, Hershman JM. Low serum thyrotropin (thyroid-stimulating hormone) in older persons without hyperthyroidism. Arch Intern Med. 1991; 151:165-8.
87. Sundbeck G, Jagenburg R, Johansson P-M, Eden S, Lindstedt G. Clinical significance of low serum thyrotropin concentration by chemiluminetric assay in 85 year-old women and men. Arch Intern Med. 1991;151:549-56.
88. Stott DJ, McLellen AR, Finlayson J, Alexander WD. Elderly patients with suppressed serum TSH but normal free thyroid hormone levels usually have mild thyroid overactivity and are at increased risk of developing overt hyperthyroidism. QJM. 1991;78:77-84.
89. Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med. 1994;331:1249-52.
90. Fischer HRA, Hackeng WHL, Schopman W, Silberbusch J. Analysis of factors in hyperthyroidism, which determine the duration of suppresslve treatment before recovery of thyroid stimulating hormone secretion. Clin Endocrinol. 1982;16:575-85.
91. 131 therapy for thyrotoxicosis. J Clin Endocrinol Metab. 1974;39:607-9.
92. Nagai K, Tamai H, Mukuta T, et al. A follow-up of 85 patients with Graves' disease in remission who develop undetectable serum thyroid-stimulating hormone concentrations using sensitive TSH assays. Horm Res. 1991;35:185-9.
93. Ross DS. Subclinical hyperthyroidism: possible danger of over-zealous thyroxine replacement therapy. Mayo Clin Proc. 1988;63:1223-9.
94. Toft AD. Thyroxine therapy. N Engl J Med. 1994;331:174-80.
95. Pacchiarotti A, Martino E, Bartalena L, et al. Serum thyrotropin by ultrasensitive immunoradiometric assay and serum free thyroid hormones in pregnancy. J Endocrinol Invest. 1986;9:185-9.
96. Ball R, Freedman DB, Holmes JC, Midgley JEM, Sheehan CP. Low-normal concentrations of free thyroxine in serum in late pregnancy: physiological fact, not technical artifact. Clin Chem. 1989; 35:1891-6.
97. Taimela E, Tahtela R, Koskinen P, et al. Ability of two new thyrotropin (TSH] assays to separate hyperthyroid patients from euthyroid patients with low TSH. Clin Chem. 1994;40:101-5.
98. Becker DV, Bigos ST, Gaitan E, et al. Optimal use of blood tests for assessment of thyroid function [letter]. JAMA. 1993;269:A2736.
99. Ross DS, Daniels GH, Goubeia D. The use and limitations of a chemiluminescent thryotropin assay as a single thyroid function test in an out-patient endocrine clinic. J Clin Endocrinol Metab. 1990;71:764-9.
100. Schectman JM, Pawlson LG. The cost-effectiveness of three thyroid function testing strategies for suspicion of hypothyroidism in a primary care setting. J Gen Intern Med. 1990;5:9-15.
101. de los Santos ET, Starich GH, Mazzaferri EL. Sensitivity, specificity, and cost-effectiveness of the sensitive thyrotropin assay in the diagnosis of thyroid disease in ambulatory patients. Arch Intern Med 1989;149:526-32.
102. Helfand M, Crapo LM. Screening for thyroid disease. Ann Intern Med. 1990;112:840-9.